ARTICLE | Company News
Celtrix other research news
October 25, 1993 7:00 AM UTC
CTRX received a two-year grant valued at $600,000 from the Office of Orphan Products Develoment of the FDA to fund Phase III trials of BetaKine for use in treating macular holes. ...